Concepedia

Paul E. Morin

PE

34

Publications

2.8K

Citations

25

H-Index

1990

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of Toronto

Johns Hopkins University

Bristol-Myers Squibb (Sweden)

Paul E. Morin is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1990–2021

34

Publications

34

Use of MM-PBSA in Reproducing the Binding Free Energies to HIV-1 RT of TIBO Derivatives and Predicting the Binding Mode to HIV-1 RT of Efavirenz by Docking and MM-PBSA

Junmei Wang, Paul E. Morin, Wei Wang et al. · Journal of the American Chemical Society · 2001 · 707 citations

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Anna-Larissa N. Niemeijer, David Leung, Marc C. Huisman et al. · Nature Communications · 2018 · 460 citations · Full text

Synthesis and Biologic Evaluation of a Novel <sup>18</sup>F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression

David J. Donnelly, R. Adam Smith, Paul E. Morin et al. · Journal of Nuclear Medicine · 2017 · 190 citations · Full text

Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor

Craig R. Johnson, Paul E. Morin, C.H. Arrowsmith et al. · Biochemistry · 1995 · 120 citations

Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase

Robert G. Gentles, Min Ding, John A. Bender et al. · Journal of Medicinal Chemistry · 2014 · 98 citations · Full text

Rows per page

1–5 of 34